Markets:

Overview

News

Currencies

International

Treasuries

BeiGene, Ltd. - American Depositary Shares (NQ:BGNE)

184.71 UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 31, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about BeiGene, Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Enlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors ↗

April 11, 2023

This month, Enlivex Therapeutics Ltd.

Via Benzinga

Why BeiGene Stock Jumped Thursday ↗

April 06, 2023

A collaboration deal helped send the Chinese biotech stock higher.

Via The Motley Fool

Silicon Valley Bank Collapse Might Have Limited Impact On Asia, But Confidence Seems Shaken ↗

March 13, 2023

Some Asian firms have disclosed cash deposits at troubled U.S. lender Silicon Valley Bank (NASDAQ: SIVB), known for its deep ties with the healthcare and tech sector. Most emphasized that the amounts...

Via Benzinga

BeiGene Earnings Perspective: Return On Capital Employed ↗

March 02, 2023

Via Benzinga

Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk ↗

February 27, 2023

US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could...

Via Benzinga

4 Analysts Have This to Say About BeiGene ↗

January 20, 2023

Via Benzinga

FDA Approves BeiGene's Brukinsa For Chronic Lymphocytic Leukemia ↗

January 20, 2023

Via Benzinga

Zymeworks Cancer Candidate Shows Objective Response Of 41% In Bile Duct Cancer ↗

December 19, 2022

Via Benzinga

BeiGene Earnings Perspective: Return On Capital Employed ↗

December 12, 2022

Via Benzinga

Week In Review: Keymed/Lepu Sign $1.2 Billion Deal Out-Licensing Claudin 18.2 ADC To AstraZeneca ↗

February 25, 2023

Keymed Bio and Lepu Biopharma out-licensed global rights for their antibody drug conjugate to AstraZeneca in a deal that includes $63 million upfront. Meanwhile, the $937 million agreement between...

Via Talk Markets

Five Best And Worst Performing Healthcare Stocks In January 2023 ↗

February 05, 2023

After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022. As well, 2023 is expected to be another promising year for the sector. Let’s take a look at the five best and...

Via Talk Markets

Is Johnson & Johnson Still a Good Dividend Stock to Buy? ↗

January 26, 2023

A disappointing fourth-quarter performance has some investors worried about the giant healthcare conglomerate's outlook.

Via The Motley Fool

Five Best And Worst Performing Healthcare Stocks In December 2022 ↗

January 22, 2023

Multiple factors are expected to help the healthcare industry overcome inflationary pressures. If you are looking to invest in this sector, then to help you select, here are the five best and worst...

Via Talk Markets

Draganfly To Rally Around 87%? Here Are 10 Other Analyst Forecasts For Friday ↗

January 20, 2023

SVB Leerink raised the price target for BeiGene, Ltd. (NASDAQ: BGNE) from $236 to $300. SVB Leerink analyst Andrew Berens maintained an Outperform rating. BeiGene shares rose 2% to $279.90 in...

Via Benzinga

What 5 Analyst Ratings Have To Say About BeiGene ↗

December 12, 2022

Via Benzinga

Will Investors Notice Exciting Sign On BeiGene's Chart? ↗

December 06, 2022

Via Benzinga

Why Shares of BeiGene Were Up Wednesday ↗

December 01, 2022

The Chinese pharmaceutical stock is experiencing a comeback.

Via The Motley Fool

These Were The Five Best And Worst Performing Large-Cap Stocks In Q4 2022 ↗

January 06, 2023

The year 2022 proved to be the worst calendar year for the S&P 500 since 2008. The benchmark index dropped more than 5% in December and almost 20% for the full year. Let’s take a look at the five best...

Via Talk Markets

Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗

December 27, 2022

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.

Via Benzinga

Week In Review: Boston Scientific Pays $523 Million For Majority Stake In Beijing Acotec Scientific ↗

December 17, 2022

Boston Scientific will pay $523 million for a 65% stake in Acotec Scientific, a Beijing medical device company. Boston Scientific said the acquisition will build up its presence in China, and it will...

Via Talk Markets

PayPal To Rally Around 47%? Here Are 10 Other Price Target Changes For Monday ↗

December 12, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About BeiGene ↗

November 10, 2022

Analysts have provided the following ratings for BeiGene (NASDAQ:BGNE) within the last quarter:

Via Benzinga

Is This Chinese Pharmaceutical Stock Worth the Risk? ↗

November 03, 2022

BeiGene's shares are down this year, but it has two potential blockbusters.

Via The Motley Fool

BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating ↗

December 08, 2022

On Thursday, China-based BeiGene stock cleared that desired 80-plus benchmark, with a jump to 82 from 77 a day earlier.

Via Investor's Business Daily

Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session ↗

November 30, 2022

Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.

Via Benzinga

Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday ↗

November 30, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket ↗

November 30, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) shares rose 33.3% to $0.2399 in pre-market trading after jumping 45% on Tuesday. Kalera recently announced restructuring process for German...

Via Benzinga

Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday ↗

November 23, 2022

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Tesla, Amazon, Coupang, Rivian, Beigene: Musk's Share Sale, Antitrust Lawsuit, Earnings Grab Retail Investors' Eyeballs ↗

November 09, 2022

Major Wall Street indices closed nearly 2% lower on Wednesday after the day was marred by uncertainties including the outcome of the mid-term elections and a sell-off in the cryptocurrency...

Via Benzinga

Jazz Obtains Exclusive Rights To Zymeworks' Cancer Candidate In Almost $2B Biobuck Deal ↗

October 19, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

BeiGene, Ltd. - American Depositary Shares (NQ:BGNE)

Headline News about BeiGene, Ltd. - American Depositary Shares

Starting at $3.75/week.

Subscribe Today